PMC:7299399 / 21519-21793
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T99","span":{"begin":180,"end":184},"obj":"Body_part"}],"attributes":[{"id":"A99","pred":"fma_id","subj":"T99","obj":"http://purl.org/sig/ont/fma/fma67122"}],"text":"e are no such kinds of vaccines on the market, and it is unknown whether they can be effective in humans. Moderna, for instance, has generated preliminary safety data on different mRNA-based vaccines targeting other respiratory viruses, but their more advanced program (on a"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T218","span":{"begin":98,"end":104},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_9606"},{"id":"T219","span":{"begin":129,"end":132},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"},{"id":"T220","span":{"begin":228,"end":235},"obj":"http://purl.obolibrary.org/obo/NCBITaxon_10239"},{"id":"T221","span":{"begin":273,"end":274},"obj":"http://purl.obolibrary.org/obo/CLO_0001020"}],"text":"e are no such kinds of vaccines on the market, and it is unknown whether they can be effective in humans. Moderna, for instance, has generated preliminary safety data on different mRNA-based vaccines targeting other respiratory viruses, but their more advanced program (on a"}
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"327","span":{"begin":98,"end":104},"obj":"Species"},{"id":"329","span":{"begin":216,"end":227},"obj":"Species"}],"attributes":[{"id":"A327","pred":"tao:has_database_id","subj":"327","obj":"Tax:9606"},{"id":"A329","pred":"tao:has_database_id","subj":"329","obj":"Tax:12814"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"e are no such kinds of vaccines on the market, and it is unknown whether they can be effective in humans. Moderna, for instance, has generated preliminary safety data on different mRNA-based vaccines targeting other respiratory viruses, but their more advanced program (on a"}